EternaTear is developing a next-generation therapy for the $2B over-the-counter dry eye market.
Location: United States
Employees: 1-10
Total raised: $4.9M
Founded date: 2018
Investors 7
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.10.2020 | Series A | $4.9M | Keiretsu F... |